YARGESA
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Feb 2022)
What this means for you
This application is over — abandoned 21 Feb 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87918216
- Mark type
- Stylized text
- Filed
- 11 May 2018
- Published for opposition
- 20 Nov 2018
- Abandoned
- 21 Feb 2022
- Attorney of record
- Daniel G. Worley Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of adult patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option due to allergy, hypersensitivity, or poor venous access; Therapeutic pharmaceutical for the treatment of adult patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option due to allergy, hypersensitivity, or poor venous access
Owner
- Edenbridge Pharmaceuticals, LLC, Parsippany, NJ, US
- Edenbridge Pharmaceuticals, LLC, Parsippany, NJ, US
Prosecution history
- 22 Feb 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Feb 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 16 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2021 — SOU EXTENSION 5 GRANTED
- 07 Jul 2021 — SOU EXTENSION 5 FILED
- 15 Jul 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Jul 2021 — SOU TEAS EXTENSION RECEIVED
- 12 Jan 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2021 — SOU EXTENSION 4 GRANTED
- 08 Jan 2021 — SOU EXTENSION 4 FILED
- 08 Jan 2021 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 11 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2020 — SOU EXTENSION 3 GRANTED
- 09 Jul 2020 — SOU EXTENSION 3 FILED